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One-Step Approach to
Identifying Gestational
Diabetes Mellitus: Association
With Perinatal Outcomes
We read with interest the retrospec-
tive before-and-after study by Poco-
belli et al1 in the October 2018 issue
comparing a period of testing with the
two-step approach with a subsequent
period of testing with the one-step
approach for gestational diabetes mel-
litus (GDM). Pocobelli et al state that,
“No randomized trial has been pub-
lished comparing outcomes of the
two approaches.”
Four randomized controlled trials
(RCTs) comparing the one-step with
the two-step approach for GDM test-
ing have been published: two from
the United States,2,3 one from Cana-
da,4 and one from Turkey.5 In these
RCTs, women were randomized to
be screened for GDM with either
the one-step or two-step approach.
A meta-analysis of these four RCTs,
including 2,617 women, recently re-
ported that the incidence of GDM
was not signiﬁcantly increased (from
4.4% to 8.3%), mothers gained 1.3 kg
less weight, and patients experienced
a nonsigniﬁcant 34% decrease in pre-
eclampsia, comparing the one-step
with the two-step approach, respec-
tively.6 The one-step approach was
also associated with some neona-
tal beneﬁts, including signiﬁcantly
decreased incidences of large for ges-
tational age by 57%, hypoglycemia
by 48%, and intensive care admission
by 51%. Neonatal death occurred in
one neonate of a mother randomized
to the one-step test, and four neo-
nates of mothers randomized to the
two-step test (a 74% nonsigniﬁcant
decrease for the one-step test).6 Test
of heterogeneity in the meta-analysis
and of quality all pointed to better
outcomes in the one-step test group.6
We want to make sure that readers
are aware of this prospective evi-
dence from RCTs, too.
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In Reply:
We agree with Berghella et al that
it is important to consider our results
in context, including considering re-
sults from their recent randomized
controlled trial (RCT)1 and meta-anal-
ysis.2 We appreciate that they ob-
tained unpublished data from a prior
RCT that previously reported ﬁndings
only for women who tested negative
for gestational diabetes mellitus
(GDM).3 However, we interpret the
results from their meta-analysis some-
what differently. In their letter, they
highlight some nonstatistically signiﬁ-
cant ﬁndings associated with receipt of
the one-step compared with the two-
step approach; speciﬁcally, lesser ges-
tational weight gain and decreased
risks of preeclampsia and neonatal
death. However, the amount of uncer-
tainty associated with those ﬁndings is
worth noting. The upper bounds of
the 95% CIs show that their results
were also consistent with a 3.5-kg
mean gestational weight gain, a 3.0-
fold increased risk of preeclampsia,
and a 2.3-fold increased risk of neo-
natal death with the one-step strategy.
The data on gestational weight gain
came from a single study of 47
women,4 and all neonatal deaths
(n55) were from unpublished data
from a single study.3 Berghella et al
also point to a statistically signiﬁcant
decreased risk of neonatal intensive
care unit (NICU) admission, but
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